Sandbox Reserved 1095: Difference between revisions

Revision as of 20:42, 12 January 2020 view source Eléna Coulier (talk \| contribs) 42 edits No edit summary ← Older edit		Revision as of 20:51, 12 January 2020 view source Eléna Coulier (talk \| contribs) 42 edits No edit summary Newer edit →
Line 51:		Line 51:

	Several anti-hypertensive drugs are targeting the angiotensin receptor in order to block it. This is the case for drugs called [https://en.wikipedia.org/wiki/Angiotensin_II_receptor_blocker angiotensin receptor blockers (ARBs)] like [https://en.wikipedia.org/wiki/Olmesartan olmesartan], [https://en.wikipedia.org/wiki/Candesartan candesartan], and [https://en.wikipedia.org/wiki/Losartan losartan]. One of the common characteristic they share is their biphenyl-tetrazole scaffold.		Several anti-hypertensive drugs are targeting the angiotensin receptor in order to block it. This is the case for drugs called [https://en.wikipedia.org/wiki/Angiotensin_II_receptor_blocker angiotensin receptor blockers (ARBs)] like [https://en.wikipedia.org/wiki/Olmesartan olmesartan], [https://en.wikipedia.org/wiki/Candesartan candesartan], and [https://en.wikipedia.org/wiki/Losartan losartan]. One of the common characteristic they share is their biphenyl-tetrazole scaffold.
			[[Image:Sartan_drugs.png]]

Navigation menu